| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/27/2005 | CN1212398C Novel IFN receptor 1 binding proteins, DNA encoding them, and method of modulating cellular response to interferons |
| 07/27/2005 | CN1212387C Fine rod bundle spore SX-1 separated and cultured from cordyceps and its culture process and use |
| 07/27/2005 | CN1212381C Fruit kernel extracted from plant fruit kernel, its extraction method, medicinal composite |
| 07/27/2005 | CN1212334C Human siali acid conjugated immunoglobulin-like agglutinant, its coding sequence and use |
| 07/27/2005 | CN1212299C Purification of xanthophylls from marigold extracts containing high levels of chlorophylls |
| 07/27/2005 | CN1212166C Safety shield system for prefilled syringes |
| 07/27/2005 | CN1212155C CD 40 binding molecules and CTL peptides for treating tumors |
| 07/27/2005 | CN1212154C Gel delivery vehicles for anticellular proliferative agent |
| 07/27/2005 | CN1212153C Immunologic adjuvant origniated from plants, and its preparing method and use |
| 07/27/2005 | CN1212151C Capsule of cordyceps |
| 07/27/2005 | CN1212131C Composition for increasing leukocytes and its use |
| 07/26/2005 | US6921826 Thioether substituted imidazoquinolines |
| 07/26/2005 | US6921825 Pyrazolo-triazolo- pyrimidine, triazolo-triazolo-pyrimidine and imidazolo-triazolo-pyrimidine derivatives useful for the treatment of hypertension, inflammation, mast cell degranulation, cardiac hypoxia, and ischemia |
| 07/26/2005 | US6921824 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents |
| 07/26/2005 | US6921772 Methods and compositions for the treatment of chronic lymphocytic leukemia |
| 07/26/2005 | US6921768 Cytostatic cerium compounds |
| 07/26/2005 | US6921765 1-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors |
| 07/26/2005 | US6921763 Protein kinase inhibitors |
| 07/26/2005 | US6921762 Substituted indolizine-like compounds and methods of use |
| 07/26/2005 | US6921761 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/26/2005 | US6921749 Polypeptides derived from endostatin exhibiting antiangiogenic activity |
| 07/26/2005 | US6921650 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 07/26/2005 | US6921644 Nucleotie sequences coding polypeptide for use in the treatment of reproductive disorders |
| 07/26/2005 | US6921526 Gastrin receptor-avid peptide conjugates |
| 07/26/2005 | CA2324848C Method of making camptothecin and camptothecin analogs |
| 07/26/2005 | CA2315481C Selective inhibition of aggrecanase in osteoarthritis treatment |
| 07/26/2005 | CA2269115C Monovalent antibody fragments |
| 07/26/2005 | CA2153326C Taxane formulations comprising phospholipids |
| 07/26/2005 | CA2076961C Igg-1 human monoclonal antibody reactive with an hiv-1 glycoprotein and method of use |
| 07/22/2005 | CA2455659A1 Barhl2 proteins, genes encoding the same and uses thereof |
| 07/21/2005 | WO2005066194A1 Helix 12 directed steroidal pharmaceutical products |
| 07/21/2005 | WO2005065720A1 Therapeutic agent for treatment of cancer comprising human apolipoprotein (a) kringles lk68 or lk8 genes as effective ingredient, and method for treating cancer using the same |
| 07/21/2005 | WO2005065719A1 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in combination therapies for the treatment of cancer |
| 07/21/2005 | WO2005065671A1 Preventive for the onset of liver cancer comprising quinone compound as the active ingredient |
| 07/21/2005 | WO2005065266A2 Di-substituted pyrrolotriazine compounds |
| 07/21/2005 | WO2005037866A3 Igg3 anti rhesus-d in the line yb2/0 having a high phagocytosis activity |
| 07/21/2005 | WO2005028513A3 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine |
| 07/21/2005 | WO2005020911A3 Benzo[1, 3]dioxole compounds, pharmaceutical compositions thereof, and processes of making and using the same |
| 07/21/2005 | WO2004089962A3 New carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them |
| 07/21/2005 | WO2004024064A8 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | WO2004018648A3 Methods for treating patients and identifying therapeutics |
| 07/21/2005 | WO2003057160A8 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | US20050160483 Glycosaminoglycan deficient proteoglycan expressed in recombinant goat; antiscarring agents and reconstructive/cosmetic surgery |
| 07/21/2005 | US20050159589 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 07/21/2005 | US20050159484 Medicament |
| 07/21/2005 | US20050159474 Chemical compounds |
| 07/21/2005 | US20050159468 Drugs for antiproliferation agent for pyrrolidine compounds |
| 07/21/2005 | US20050159463 5-methoxy-3-(2-(2-furamido) ethyl)indole; related to melatonin, but pharmacologicaly and pharmacokineticy different; longer duration, selective localization and greater efficacy |
| 07/21/2005 | US20050159462 Elevates extracellular adenosine concentration for antiinflammatory and immunosuppressive effects; reaction of imidazole-4-carboxamide with a hydroxyalkylbenzoxazole or benzothiazole compound; 1-[4-hydroxy-1-(2-phenyl-4-benzoxazolyl)-3-pentyl]-imidazole-4-carboxamide |
| 07/21/2005 | US20050159461 Treating cancer with a synergistic mixtures; anticarcinogenic agents; epothilone has secondary amide instead of an ester |
| 07/21/2005 | US20050159456 Method of treating of demyelinating diseases or conditions |
| 07/21/2005 | US20050159447 Quinoline derivative anticarcinogenic compounds; based on herbicides |
| 07/21/2005 | US20050159435 [3-Methyl-4-(pyridin-3-yloxy)-phenyl]-(6-piperidin-3-ylethynyl-quinazolin-4-yl)-amine; selective inhibitors of receptor tyrosine kinases and non-receptor tyrosine kinases (eg: Ick, src, abl) or serine/threonine kinases (e.g.: cyclin dependent kinases); carcinoma |
| 07/21/2005 | US20050159434 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl)-3-oxo-propionitrile mono citrate salt; immunosuppressants, autoimmune diseases, skin disorders, Crohn's disease, antidiabetic agents, anticancer agents, antiarthritic agents |
| 07/21/2005 | US20050159426 Novartis drug called Imatinib, 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide, methanosulfonate; synergistic mixture with a second antineoplastic agent |
| 07/21/2005 | US20050159422 Inhibitors of akt activity |
| 07/21/2005 | US20050159421 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 07/21/2005 | US20050159407 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 07/21/2005 | US20050159405 Substituted 10-aryl-11h-benzo[b]fluourenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 07/21/2005 | US20050159401 Treating atheroma, tumors and other neoplastic tissue; treating atherosclerotic inflammation; forming a complexes with a reducing agent, penetrate and accumulate more rapidly in tumor cells, plaque, increase drug in intracellular concentration; increase photosensitivity |
| 07/21/2005 | US20050159397 vitamin D3 derivative as anti-cancer agent, for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion, for immune disorders, metabolic bone diseases and also used as antiinflammatory agent |
| 07/21/2005 | US20050159395 Topical applying to skins; skin disorders; anticarcinogenic agents |
| 07/21/2005 | US20050159392 Phosphoramidate linkages; retroviral or hepadnaviral therapy; tissue targeted therapy; HIV/aquired immunodeficiency syndrome; antitumor agents; improved bioavailability |
| 07/21/2005 | US20050159386 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 07/21/2005 | US20050159373 Novel polypeptides, and nucleic acids encoding the same |
| 07/21/2005 | US20050159361 Luteinizing hormone releasing hormone receptor agonist/antagonist (leuprorelin) and steroidal androgen receptor agonist (dehydroepiandrosterone, testosterone); sustained release |
| 07/21/2005 | US20050159360 Improved bioavailability |
| 07/21/2005 | US20050159359 Methods and compositions for derepression of IAP-inhibited caspase |
| 07/21/2005 | US20050159335 Pharmaceutical administration form for peptides, process for its preparation, and use |
| 07/21/2005 | US20050159332 Ntb-a,a a surface molecule involved in natural killer cellss activity |
| 07/21/2005 | US20050158828 Preparing immunoglobulin dimer for use in prevention and treatment of B cell lymphoma and chronic lymphocytic leukemia; immunotherapeutics |
| 07/21/2005 | US20050158808 Identifying transcriptional inhibitor which modulates activity of small ubiquitin-related modifier proteins (SUMO) and protein inhibitor of activated STAT ( PIAS ) for use in prevention and treatment of cell proliferative disorders |
| 07/21/2005 | US20050158800 Detecting the expression of a G-protein coupled receptor, identifying agonists or antagonists of the receptor |
| 07/21/2005 | US20050158785 Non-peptide compounds 2-(5(6)-nitro-2-benzimidazoyl)-5-(4-nitrophenyl)furan; for use in bioassay, fluorescent quantitative analysis; control of gene expression, treatment/prevention of cancer |
| 07/21/2005 | US20050158780 Nucleic acid ligands to the prostate specific membrane antigen |
| 07/21/2005 | US20050158753 Using presence of gastrointestinal system protein (CS141) as diagnostic indcator of gastrointestinal disorders; diagnosing colon and rectum cancer |
| 07/21/2005 | US20050158726 Compositons and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 07/21/2005 | US20050158724 Methods, of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 07/21/2005 | US20050158719 Polypeptide serving as angiogenic marker and dna thereof |
| 07/21/2005 | US20050158703 Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy |
| 07/21/2005 | US20050158608 Method for manufacturing a layer lamination integrated fuel cell and the fuel cell itself |
| 07/21/2005 | US20050158317 Novel proteins with il-6 inhibiting activity |
| 07/21/2005 | US20050158305 Monoclonal antibody for treatment of cancer, autoimmune diseases and rheumatoid arthritis; complementarity determining regions |
| 07/21/2005 | US20050158288 Methods of organ regeneration |
| 07/21/2005 | US20050158278 Means and methods for the production of adenovirus vectors |
| 07/21/2005 | US20050158244 Cell population from staining a neoplastic cell population with a first marker, staining a dendritic cell population with a second marker, fusing the cells to obtain hybrid cell population stained with both markers; purifying |
| 07/21/2005 | US20050158242 Detecting presence of selected cancer by measuring levels of Cancer Specific Genes(CSG) in cells, tissues or bodily fluids and comparing levels with levels of CSG from normal human control, wherein change in measured levels is associated with presence of selected cancer; gynecologic and lung cancers |
| 07/21/2005 | US20050158241 Novel method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 07/21/2005 | DE10024383B4 Mit toxischen Substanzen beladene dendritische Zellen With toxic substances loaded dendritic cells |
| 07/21/2005 | CA2553211A1 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in combination therapies for the treatment of cancer |
| 07/21/2005 | CA2552590A1 Interleukin-12 targeted to oncofoetal fibronectin |
| 07/21/2005 | CA2552101A1 Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds |
| 07/21/2005 | CA2551524A1 Treatment of malignant gliomas with tgf-beta inhibitors |
| 07/21/2005 | CA2550709A1 Preventive for the onset of liver cancer comprising quinone compound as the active ingredient |
| 07/20/2005 | EP1555021A1 Combinations of a mevalonate pathway inhibitor and a PPAR-gamma agonist for treating cancer |
| 07/20/2005 | EP1554572A2 Compositions and methods for modulating blood-brain barrier transport |
| 07/20/2005 | EP1554393A2 P27 prevents cellular migration |
| 07/20/2005 | EP1554375A2 Adenovirus expressing genes in reverse order and use thereof |
| 07/20/2005 | EP1554304A1 Ship 1 modulators |
| 07/20/2005 | EP1554298A1 Process for the preparation of 9-beta-anomeric nucleoside analogs |